Patents by Inventor Nicolas MONJOTIN

Nicolas MONJOTIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
    Patent number: 10265322
    Abstract: The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: April 23, 2019
    Assignee: Pierre Fabre Medicament
    Inventors: Bruno Le Grand, Didier Junquero, Nicolas Monjotin
  • USE OF PAR-1 ANTAGONISTS FOR PREVENTING AND/OR TREATING PELVI-PERINEAL FUNCTIONAL PATHOLOGICAL CONDITIONS
    Publication number: 20180311253
    Abstract: The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
    Type: Application
    Filed: April 25, 2018
    Publication date: November 1, 2018
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Bruno LE GRAND, Didier JUNQUERO, Nicolas MONJOTIN
  • Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
    Patent number: 9980970
    Abstract: The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: May 29, 2018
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Bruno Le Grand, Didier Junquero, Nicolas Monjotin
  • USE OF PAR-1 ANTAGONISTS FOR PREVENTING AND/OR TREATING PELVI-PERINEAL FUNCTIONAL PATHOLOGICAL CONDITIONS
    Publication number: 20160287603
    Abstract: The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
    Type: Application
    Filed: October 31, 2014
    Publication date: October 6, 2016
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Bruno LE GRAND, Didier JUNQUERO, Nicolas MONJOTIN